AI drug discovery

DeepMind has unlocked protein-based medicine – what does that mean for drug patents?

AI drug discovery, Artificial Intelligence, BioPharma, biopharma nl, Daily, Legal, News, patent law, SYN, Top Story, United States Patent and Trademark Office / August 30, 2021

One of science’s great puzzles is being solved by artificial intelligence and the answers shared freely on the internet. How can life sciences companies make the most of DeepMind’s discoveries while protecting their own?

HiberCell’s Genuity buyout brings $100M, plus alliances with Ionis and AbbVie

AI drug discovery, Artificial Intelligence, BioPharma, biopharma nl, cancer, Daily, deals, Genuity Science, HiberCell, New York, Startups, SYN, Top Story / August 16, 2021

Startup HiberCell has acquired Genuity Science, a marriage that brings together two companies that apply AI and machine learning to drug research. HiberCell says Genuity will help the company identify and validate new pathways in how cancer starts and progresses.

AI-driven Deep Genomics gets $180M to turn biology into informational medicines

AI drug discovery, Artificial Intelligence, BioPharma, Brendan Frey, Daily, Deep Genomics, investing, Startups, SYN, Top Story, Toronto / July 28, 2021

Softbank led the Series C round of funding for Deep Genomics, a startup that applies its artificial intelligence technology to all aspects of discovering and developing new drugs. The Deep Genomics platform has yielded 10 programs; CEO Brendan Frey aims to advance four of them to the clinic in two years, all while tripling the …

AI-driven Deep Genomics gets $180M to turn biology into informational medicines Read More »

Engine Biosciences revs up $43M for AI tech that yields targeted cancer therapies

AI drug discovery, Artificial Intelligence, BioPharma, biopharma nl, California, cancer, Daily, Engine Biosciences, investing, san carlos, singapore, Startups, SYN, Top Story / May 26, 2021

Engine Biosciences closed a $43 million Series A financing that the startup will apply to its artificial intelligence-based technology for drug discovery. The company analyzes genetic interactions, “deciphering biology” to find new cancer drugs.

en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu